8-KEarnings & ResultsFinancial EventsRegulation FD+1

QUEST DIAGNOSTICS INC 8-K Report, Financial Results (Jan 29, 2015)

Filed January 29, 2015For Securities:DGX

Summary

Quest Diagnostics Incorporated (DGX) filed an 8-K on January 29, 2015, to report its financial results for the fourth quarter and full year ended December 31, 2014, as detailed in a press release (Exhibit 99.1). The company also disclosed significant updates regarding a multi-year operational excellence and cost reduction program, aiming for $600 million in run rate savings by the end of 2017. A key development is the adoption of a course of action for this program, with an estimated pre-tax charge of $300 million. While a detailed breakdown of total charges is pending, the company provided an initial estimate for 2015, expecting charges between $95 million and $115 million, primarily for employee separation, facility-related costs, and systems conversion. This proactive restructuring indicates a strategic move to enhance efficiency and profitability, though investors should note that these charges will impact earnings.

Key Highlights

  • 1Quest Diagnostics announced Q4 and full-year 2014 results via press release on January 29, 2015.
  • 2The company is implementing a multi-year program targeting $600 million in run rate savings by year-end 2017.
  • 3An estimated pre-tax charge of $300 million is associated with the new operational excellence program.
  • 4Initial 2015 estimated pre-tax charges for the program range from $95 million to $115 million.
  • 5These 2015 charges include employee separation, facility costs, asset impairment, and systems conversion.
  • 6The company provided historical data on amortization expense and adjusted diluted EPS (excluding amortization) from 2012-2014 to offer better context for its 2015 outlook.

Frequently Asked Questions

The 8-K filing references a press release (Exhibit 99.1) dated January 29, 2015, which announced the company's financial results for the fourth quarter and full year ended December 31, 2014. Specific figures are not detailed within the 8-K text itself but are available in the referenced press release.

The company is undertaking a multi-year program to drive operational excellence and reduce its cost structure, aiming for $600 million in run rate savings by the end of 2017. This initiative involves standardizing processes, IT systems, and equipment, and enhancing electronic services and reimbursement. The program is estimated to incur pre-tax charges totaling $300 million, with a significant portion expected in 2015.

For 2015, Quest Diagnostics has estimated pre-tax charges for the program to be between $95 million and $115 million. This includes an estimated $25 million to $30 million for employee separation, $10 million to $15 million for facility-related costs and asset impairment, and $60 million to $70 million for systems conversion and integration. Most of these estimated 2015 charges are expected to result in cash expenditures.

The company is providing information on its 2015 outlook, including adjusted diluted EPS excluding amortization expense. To help investors understand this outlook better, Quest Diagnostics is also providing historical data (January 1, 2012, through December 31, 2014) on amortization expense from continuing operations and adjusted diluted EPS excluding amortization (Exhibit 99.2).